Literature DB >> 15789066

Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics.

D Primo1, M D Tabernero, J J Perez, A Rasillo, J M Sayagués, A B Espinosa, M C Lopez-Berges, R García-Sanz, N C Gutierrez, J M Hernandez, M Romero, C S Osuna, M Giralt, M Barbon, J F San Miguel, A Orfao.   

Abstract

Philadelphia-positive (Ph(+)) B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is a genetically heterogeneous disease with a very poor prognosis. In this study, we analyzed the frequency of supernumerary Ph, trisomy 8, monosomy 7, and del(9p21) by FISH and its relationship with the characteristics of the disease, in 46 BCR/ABL(+) adult BCP-ALL patients. The frequency of supernumerary Ph, trisomy 8, monosomy 7 and del(9p21) was 30%, 20%, 15%, and 24%, respectively. Although all patients displayed a BII/common phenotype, supernumerary Ph and trisomy 8 were associated with higher expression of CD19 and CD22 and of CD19, CD34, CD45, and HLA-DR, respectively; in turn, cases with monosomy 7 showed lower CD19, CD22, CD34, and cCD79a and del(9p21)(+) blasts were CD13(-) and CD33(-). Overall, similar clinical and hematological features were observed at presentation, independently of the underlying genetic abnormalities. However, relapse-free survival (RFS) was significantly shorter in cases with supernumerary Ph, trisomy 8, and del(9p21), the latter being the most powerful independent prognostic factor for RFS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15789066     DOI: 10.1038/sj.leu.2403714

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  12 in total

Review 1.  Primary testicular Ph-positive B lymphoblastic lymphoma: an unusual presentation and review.

Authors:  Jiling Zhu; Shiying Zhang; Li Zhu; Xinlu Li; Ying Wang; Yaqi Duan; Wei Huang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors.

Authors:  Jesse Jaso; Deborah A Thomas; Krista Cunningham; Jeffrey L Jorgensen; Hagop M Kantarjian; L Jeffrey Medeiros; Sa A Wang
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

3.  Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.

Authors:  Richard T Williams; Martine F Roussel; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

4.  Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.

Authors:  Richard T Williams; Willem den Besten; Charles J Sherr
Journal:  Genes Dev       Date:  2007-08-30       Impact factor: 11.361

5.  High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.

Authors:  Faith M Young; Andrew Campbell; Kris Lambert Emo; Johan Jansson; Pin-Yi Wang; Craig T Jordan; Craig A Mullen
Journal:  Biol Blood Marrow Transplant       Date:  2008-04-14       Impact factor: 5.742

6.  Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients.

Authors:  Jian-Hua Yu; Jing-Tao Dong; Yong-Qian Jia; Neng-Gang Jiang; Ting-Ting Zeng; Hong Xu; Xian-Ming Mo; Wen-Tong Meng
Journal:  Chin J Cancer       Date:  2012-07-02

7.  An adult B-cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Moneeb Abdullah Kassem Othman; Faten Moassass; Abdulmunim Aljapawe; Thomas Liehr
Journal:  Mol Cytogenet       Date:  2014-09-10       Impact factor: 2.009

8.  [Clinical analysis of adult Philadelphia chromosome-positive acute lymphoblastic leukemia with p16 gene deletion].

Authors:  B L He; N Xu; Y L Li; C Y Pan; R Cao; L B Liao; C X Yin; Y Q Lan; Z Y Lu; J X Huang; H S Zhou; Q F Liu; X L Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-03-14

Review 9.  Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Kathrin M Bernt; Stephen P Hunger
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

10.  Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Na Xu; Yu-ling Li; Xuan Li; Xuan Zhou; Rui Cao; Huan Li; Lin Li; Zi-yuan Lu; Ji-xian Huang; Zhi-ping Fan; Fen Huang; Hong-sheng Zhou; Song Zhang; Zhi Liu; Hong-qian Zhu; Qi-fa Liu; Xiao-li Liu
Journal:  J Hematol Oncol       Date:  2016-04-18       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.